Advancing Drug Discovery Through Innovative Technologies & Strategic Collaboration
A Concise Report Featuring Insights From The Prominent Thought Leaders Of Discovery & Automate 2024
Paving the Way For Animal Free Models by Leveraging 3D Cell Culture, Organoids & Organ Modelling
A Concise Report Featuring Insights From The Prominent Thought Leaders Of 3D Cell Culture & Organ Modelling 2024
Top R&D Stories of 2023
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Automation
AI/ML Advancements in Drug Formulation – The Potential of Self-Driving Labs
Intrepid Labs demonstrates how its self-driving lab uses ML and robotics to advance drug formulation.
AI/ML
2024 Nobel Prize in Chemistry Awarded to Pioneering Advances in Protein Design and Structure Prediction
The 2024 Nobel Prize in Chemistry was awarded to three scientists working on computational protein design and protein structure prediction.
Regulatory
Cobenfy: A Critical Breakthrough in Schizophrenia Treatment in Over 30 Years
According to a recent press release, the US FDA has approved Cobenfy, a first-in-class muscarinic agonist developed by Bristol Myers Squibb for the treatment of schizophrenia in adults.
Drug Discovery
The Power of Philanthropy in Transforming Pancreatic Cancer Research
The Stephenson Prize for innovation in pancreatic cancer research was launched alongside a $150 million gift to City of Hope.
Organ Modelling
The Role of Immuno-Organoids in Drug Discovery And Disease Modelling
A study conducted by Roche demonstrates how to create new human models with tissue-integrated immune cells.
Target Discovery
Strategic Acquisition: Otsuka Pharmaceutical to Pay Up to $1.1 billion to Acquire Jnana Therapeutics' Drug Discovery Platform
The Japanese healthcare company Otsuka Pharmaceutical will acquire clinical-stage biotech Jnana Therapeutics.
AI/ML
Exscientia and Amazon Web Services Join Forces to Maximise the Potential Of Generative AI in Drug Discovery
Exscientia, a biotech and pioneer in technology-driven drug design, has teamed up with Amazon Web Services to bolster its AI drug discovery platform.
.jpg)
AI/ML
Building Partnerships & Fostering An Inter-Disciplinary Approach In The Fight Against Anti-Microbial Resistance
This article outlines two examples of partnerships that aim to tackle the global issue of anti-microbial resistance. This overlooked yet prominent threat continues to pose challenges for scientists, policymakers, and governments.
Drug Discovery
Alzheimer's & Brain Awareness Month Spotlight: How Amphista Therapeutics is Tackling Neurological Disorders
To honour Alzheimer's & Brain Awareness Month, this article will acknowledge Amphista Therapeutics' use of targeted protein degradation (TPD) to treat symptoms of neurological disorders.
Chemical Biology
New Class of Molecular Glues Could Reshape Cancer Drug Discovery
A research group at the University of Dundee discovered new molecular glues, expanding the targeted protein degradation field.